Figures & data
![](/cms/asset/eafd2594-e806-44c9-bfa7-9100e9da3970/tbbb_a_1562875_uf0001_oc.jpg)
Figure 1. Synthesis of PEI-SPION.
Evaluations of PEI-SPION. (a) Proposed reaction scheme for the synthesis of PEI-SPION. (b) XRD pattern of SPION. (c) FT-IR images of SPION and PEI-SPION. (d) TG image of PEI-SPION. (e) Zeta potential of SPION, PEI-SPION and LP-PEI-SPION/DNA. (f) Magnetic hysteresis loops of SPION and PEI-SPION.
![Figure 1. Synthesis of PEI-SPION.Evaluations of PEI-SPION. (a) Proposed reaction scheme for the synthesis of PEI-SPION. (b) XRD pattern of SPION. (c) FT-IR images of SPION and PEI-SPION. (d) TG image of PEI-SPION. (e) Zeta potential of SPION, PEI-SPION and LP-PEI-SPION/DNA. (f) Magnetic hysteresis loops of SPION and PEI-SPION.](/cms/asset/129f1f77-ffd0-444b-9d6a-be4336ac1150/tbbb_a_1562875_f0001_b.gif)
Figure 2. Characterization of PEI-SPION. (a) TEM image of SPION. (b) TEM image of PEI-SPION. (c) TEM image of LP-PEI-SPION/DNA. (d) Size distribution study of SPION, PEI-SPION and LP-PEI-SPION/DNA.
![Figure 2. Characterization of PEI-SPION. (a) TEM image of SPION. (b) TEM image of PEI-SPION. (c) TEM image of LP-PEI-SPION/DNA. (d) Size distribution study of SPION, PEI-SPION and LP-PEI-SPION/DNA.](/cms/asset/18fcbf82-4c3b-4aa7-a031-8fb659cc32f3/tbbb_a_1562875_f0002_b.gif)
Figure 3. Agarose gel electrophoresis of LP-PEI-SPION/DNA complexes at various weight ratios, and naked DNA was as control.
![Figure 3. Agarose gel electrophoresis of LP-PEI-SPION/DNA complexes at various weight ratios, and naked DNA was as control.](/cms/asset/76599232-9d92-468a-9c20-34b239508da7/tbbb_a_1562875_f0003_b.gif)
Figure 4. Cell viability of LP-PEI-SPION/DNA complexes at various weight ratios in three different cell lines. (a) SPC-A1, (b) HepG2 and (c) A549. Data was obtained from three independent experiments (mean ± SD, n = 3).
![Figure 4. Cell viability of LP-PEI-SPION/DNA complexes at various weight ratios in three different cell lines. (a) SPC-A1, (b) HepG2 and (c) A549. Data was obtained from three independent experiments (mean ± SD, n = 3).](/cms/asset/904c66a7-60f8-414e-a9bf-22c3c2098031/tbbb_a_1562875_f0004_b.gif)
Figure 5. Transfection efficiency of LP-PEI-SPION/pGL3 complexes at various weight ratios in three different cell lines, and LP 6, Lipofectamine® 2000 (LP 2000) and naked DNA (DNA) were controls. (a) SPC-A1, (b) HepG2, (c) A549 (mean ± SD, n = 3). Compared with LP 2000, *P < 0.05.
![Figure 5. Transfection efficiency of LP-PEI-SPION/pGL3 complexes at various weight ratios in three different cell lines, and LP 6, Lipofectamine® 2000 (LP 2000) and naked DNA (DNA) were controls. (a) SPC-A1, (b) HepG2, (c) A549 (mean ± SD, n = 3). Compared with LP 2000, *P < 0.05.](/cms/asset/22c14523-2962-4b4d-afcf-38bf1ff9b9de/tbbb_a_1562875_f0005_b.gif)
Figure 6. Cell morphology after transfection with LP-PEI-SPION/DNA 6, LP/DNA 6 and LP 2000/DNA.
LP-PEI-SPION/pEGFP-N2 complexes at weight ratio 6 were transfected into SPC-A1 cells. LP and Lipofectamine® 2000 were used as controls. The transfection efficiency (%) was defined as (Number of EGFP positive cells/Number of total cells) × 100%.
![Figure 6. Cell morphology after transfection with LP-PEI-SPION/DNA 6, LP/DNA 6 and LP 2000/DNA.LP-PEI-SPION/pEGFP-N2 complexes at weight ratio 6 were transfected into SPC-A1 cells. LP and Lipofectamine® 2000 were used as controls. The transfection efficiency (%) was defined as (Number of EGFP positive cells/Number of total cells) × 100%.](/cms/asset/2c12f72f-03bc-4636-8998-5992097dbfea/tbbb_a_1562875_f0006_c.jpg)